744 Mrv0541 02231214582 d 16 0 0 1 0 999 17 V2000型3.8597 1.1874 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 5.1662 -0.9055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.8162 0.5235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.5787 -0.1910 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.8162 -0.9055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.1662 0.5235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3412 0.5235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8597 -0.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.9360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5787 1.2379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -0.3015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.9360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4037 -0.1910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 7 1 10 0 0 0 0 1 1 0 0 0 0 2 4 1 0 0 0 0 3 16 2 0 0 0 0 4 1 6 0 0 0 0 4 16 1 0 0 0 0 5 6 7 1 1 0 0 0 0 0 0 0 0 6 11 1 0 0 0 0 7 9 2 0 0 0 0 8 9 1 0 0 0 0 8 10 1 0 0 0 0 8 12 2 0 0 0 0 10 13 2 0 0 0 0 12 14 1 0 0 0 0 13 14 15 15 1 0 0 0 0 2 0 0 0 0 M >结束
DB00744 >
drugbank >
CC (N (N) (O) C = O) C1 = CC2 = CC = CC = C2S1 >
InChI = 1 s / C11H12N2O2S c1-7 (13 (15) 11 (12) 14) 10-6-8-4-2-3-5-9 / h2-7为何(8)取得16胜10负,15 h, 1 h3 (H2、12、14) >
MWLSOWXNZPKENC-UHFFFAOYSA-N >
C11H12N2O2S >
236.29 >
236.061948328 >
2 >
28日>
-0.014320312643828458 >
24.137720482183898 >
1 >
2 >
0 >
1 >
1 - [1 - (1-benzothiophen-2-yl)乙基]1-hydroxyurea >
2.01 >
2.006172834999999 >
-3.64 >
0 >
0 >
2 >
0 >
8.83778309271064 >
-5.494153581458329 >
66.56 >
61.95950000000001 >
2 >
1 >
5.39 e-02 g / l >
四氢叶酸>
0 >
DB00744 >
APRD00265 >
批准;临床实验;撤回>
与>
(±)1 - (1-Benzo [b] thien-2-ylethyl) 1-hydroxyurea;Leutrol;N - (1-Benzo (b) thien-2-ylethyl) -N-hydroxyurea;N -[1 -(苯并[b] thiophen-2-yl)乙基]-N-hydroxyurea;食品与;食品与;Zileutonum >
食品与;欣;欣CR $ $ $ $